Infectious Diseases in Obstetrics and Gynecology / 2018 / Article / Tab 4

Research Article

Universal Rapid Human Immunodeficiency Virus Screening at Delivery: A Cost-Effectiveness Analysis

Table 4

Estimated cost and effectiveness per 10,000 pregnant women.

StrategyEstimated cost ($)Estimated QALYsReference: standard of care IReference: standard of care II
Incremental cost ($)Incremental QALYICER ($/QALY)Incremental cost ($)Incremental QALYICER ($/QALY)

Universal rapid HIV screening75,606,835.51279,941.7339,827.835.017,943.4526,968.767.473,610.58
Standard of care I75,567,007.68279,936.71- -- -- -- -- -- -
Standard of care II75,579,866.75279,934.2612,859.07- -- -- -

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.